Multimodal Physiotherapy Based on Tele-rehabilitation in Chronic Pelvic Pain Associated With Endometriosis
Launched by UNIVERSITY OF ALCALA · Jan 7, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a tele-rehabilitation program can help women with chronic pelvic pain caused by endometriosis. The program includes pain education, therapeutic exercises, and breathing techniques delivered through an online platform. The researchers want to see if this approach can reduce pain levels, help with anxiety about pain, improve sexual function, and enhance the overall quality of life compared to a control group that will receive general information about endometriosis and healthy lifestyle tips.
To participate, women must be between 18 and 55 years old, have a confirmed diagnosis of endometriosis, and have been experiencing pelvic pain for at least three months. They should also be able to understand the study instructions and have access to an electronic device and email. If eligible, participants will be randomly assigned to either the tele-rehabilitation program or the control group. Throughout the study, they will complete questionnaires to track their progress before the program starts, right after it ends, and again at three and six months later. This trial is currently recruiting participants, so there is an opportunity to get involved and possibly find relief from chronic pain.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women with a medical diagnosis of endometriosis.
- • Age equal to or older than 18 years and up to 55 years.
- • Who are or have received medical and/or surgical treatment and with controlled disease.
- • Persistent pelvic pain for at least 3 months.
- • Pain greater than 4 on the EVN.
- • No cognitive limitation to understand the information sheet, instructions and freely sign the informed consent
- • Have any electronic device available (tablet, computer, cell phone).
- • Have a current email address.
- • Have a valid e-mail address.
- Exclusion Criteria:
- • Peri- and postmenopausal women.
- • Women pregnant or desiring gestation during the study.
- • Women with a history of gynecologic cancer and/or undergoing any systemic and/or localized oncologic treatment in the pelviperineal region
- • Women with a diagnosis of chronic fatigue or fibromyalgia▪.
- • Women concomitantly participating in another intervention study.
- • Women undergoing surgery during the study.
About University Of Alcala
The University of Alcalá, a prestigious institution located in Spain, is committed to advancing medical research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking studies in various fields of healthcare. By fostering partnerships with industry leaders and healthcare professionals, the University of Alcalá aims to enhance patient outcomes and contribute to the global body of medical knowledge. Its dedication to rigorous research methodologies ensures the integrity and reliability of clinical trials, promoting a culture of excellence in scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcalà De Henares, Madrid, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported